Loading…

Recurrent Idiopathic Liver Allograft Failure: The Role of Antibody-Mediated Rejection

Objectives: Many transplant programs have had patients who develop idiopathic recurrent liver allograft failure, necessitating serial transplants, and are deemed to have refractory or recurrent rejection. The frequency and the etiology of this immunologic dysfunction have not been well characterized...

Full description

Saved in:
Bibliographic Details
Published in:American journal of clinical pathology 2019-09, Vol.152 (3), p.369-376
Main Authors: Schiano, Thomas D, Florman, Sander, Fiel, M. Isabel
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 376
container_issue 3
container_start_page 369
container_title American journal of clinical pathology
container_volume 152
creator Schiano, Thomas D
Florman, Sander
Fiel, M. Isabel
description Objectives: Many transplant programs have had patients who develop idiopathic recurrent liver allograft failure, necessitating serial transplants, and are deemed to have refractory or recurrent rejection. The frequency and the etiology of this immunologic dysfunction have not been well characterized. Methods: Herein, we illustrate the case of a patient who required three retransplants over a period of 20 years for recurrent liver allograft failure. By extensively compiling the patient's many liver biopsy specimens and explants over time, we demonstrate that antibody-mediated rejection (AMR) was a major contributing factor from the outset. We conducted a review of the Scientific Registry for Transplant Recipients database to estimate the potential frequency of AMR. Results: As illustrated by this case, AMR has varied histologic findings in the setting of elevated donor-specific antibody titers. Conclusions: The cause of recurrent allograft failure in this patient was likely a combination of acute cellular rejection and AMR, manifestations of likely underlying immune dysregulation. Pathologists and transplant physicians should recognize the variable histologic presentations of AMR, which is imperative for its timely intervention. This case demonstrates how difficult the diagnosis of AMR can be to make, highlighting the need for strong clinical suspicion in patients having difficult-to-treat rejection and recurrent allograft failure. Key Words: Allograft failure; Rejection; Liver transplantation; Retransplantation
doi_str_mv 10.1093/AJCP/AQZ044
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2339156853</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A648084856</galeid><sourcerecordid>A648084856</sourcerecordid><originalsourceid>FETCH-LOGICAL-g180t-2c1d2247c9be74c86154f6b5d02c4e481b134bf6fd549a490c20351253de4f6d3</originalsourceid><addsrcrecordid>eNptjU1LAzEYhIMoWKsn_0DA87b53A9vS7FaqailvXhZssmbNmW7qdms4L93QUEPMoeB4ZkZhK4pmVBS8Gn5OHuZlq9vRIgTNKKF4EmWMXaKRoQQlhQ04-foouv2hFCWEzFCmxXoPgRoI14Y548q7pzGS_cBAZdN47dB2YjnyjV9gFu83gFe-Qawt7hso6u9-UyewDgVweAV7EFH59tLdGZV08HVj4_RZn63nj0ky-f7xaxcJluak5gwTQ1jItNFDZnQeUqlsGktDWFagMhpTbmobWqNFIUSBdGMcEmZ5AYG0PAxuvnePQb_3kMXq73vQztcVozzgso0l_yX2qoGKtdaH4PSB9fpqkxFTnKRy3SgJv9QgwwcnPYtWDfkfwpfmclsqg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2339156853</pqid></control><display><type>article</type><title>Recurrent Idiopathic Liver Allograft Failure: The Role of Antibody-Mediated Rejection</title><source>Oxford Journals Online</source><creator>Schiano, Thomas D ; Florman, Sander ; Fiel, M. Isabel</creator><creatorcontrib>Schiano, Thomas D ; Florman, Sander ; Fiel, M. Isabel</creatorcontrib><description>Objectives: Many transplant programs have had patients who develop idiopathic recurrent liver allograft failure, necessitating serial transplants, and are deemed to have refractory or recurrent rejection. The frequency and the etiology of this immunologic dysfunction have not been well characterized. Methods: Herein, we illustrate the case of a patient who required three retransplants over a period of 20 years for recurrent liver allograft failure. By extensively compiling the patient's many liver biopsy specimens and explants over time, we demonstrate that antibody-mediated rejection (AMR) was a major contributing factor from the outset. We conducted a review of the Scientific Registry for Transplant Recipients database to estimate the potential frequency of AMR. Results: As illustrated by this case, AMR has varied histologic findings in the setting of elevated donor-specific antibody titers. Conclusions: The cause of recurrent allograft failure in this patient was likely a combination of acute cellular rejection and AMR, manifestations of likely underlying immune dysregulation. Pathologists and transplant physicians should recognize the variable histologic presentations of AMR, which is imperative for its timely intervention. This case demonstrates how difficult the diagnosis of AMR can be to make, highlighting the need for strong clinical suspicion in patients having difficult-to-treat rejection and recurrent allograft failure. Key Words: Allograft failure; Rejection; Liver transplantation; Retransplantation</description><identifier>ISSN: 0002-9173</identifier><identifier>EISSN: 1943-7722</identifier><identifier>DOI: 10.1093/AJCP/AQZ044</identifier><language>eng</language><publisher>Chicago: Oxford University Press</publisher><subject>Allografts ; Antibodies ; Biopsy ; Causes of ; Development and progression ; Etiology ; Explants ; Graft rejection ; Health aspects ; Liver ; Liver diseases ; Liver transplantation ; Liver transplants ; Physiological aspects ; Transplantation ; Transplants &amp; implants ; Viral antibodies</subject><ispartof>American journal of clinical pathology, 2019-09, Vol.152 (3), p.369-376</ispartof><rights>COPYRIGHT 2019 Oxford University Press</rights><rights>American Society for Clinical Pathology, 2019. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Schiano, Thomas D</creatorcontrib><creatorcontrib>Florman, Sander</creatorcontrib><creatorcontrib>Fiel, M. Isabel</creatorcontrib><title>Recurrent Idiopathic Liver Allograft Failure: The Role of Antibody-Mediated Rejection</title><title>American journal of clinical pathology</title><description>Objectives: Many transplant programs have had patients who develop idiopathic recurrent liver allograft failure, necessitating serial transplants, and are deemed to have refractory or recurrent rejection. The frequency and the etiology of this immunologic dysfunction have not been well characterized. Methods: Herein, we illustrate the case of a patient who required three retransplants over a period of 20 years for recurrent liver allograft failure. By extensively compiling the patient's many liver biopsy specimens and explants over time, we demonstrate that antibody-mediated rejection (AMR) was a major contributing factor from the outset. We conducted a review of the Scientific Registry for Transplant Recipients database to estimate the potential frequency of AMR. Results: As illustrated by this case, AMR has varied histologic findings in the setting of elevated donor-specific antibody titers. Conclusions: The cause of recurrent allograft failure in this patient was likely a combination of acute cellular rejection and AMR, manifestations of likely underlying immune dysregulation. Pathologists and transplant physicians should recognize the variable histologic presentations of AMR, which is imperative for its timely intervention. This case demonstrates how difficult the diagnosis of AMR can be to make, highlighting the need for strong clinical suspicion in patients having difficult-to-treat rejection and recurrent allograft failure. Key Words: Allograft failure; Rejection; Liver transplantation; Retransplantation</description><subject>Allografts</subject><subject>Antibodies</subject><subject>Biopsy</subject><subject>Causes of</subject><subject>Development and progression</subject><subject>Etiology</subject><subject>Explants</subject><subject>Graft rejection</subject><subject>Health aspects</subject><subject>Liver</subject><subject>Liver diseases</subject><subject>Liver transplantation</subject><subject>Liver transplants</subject><subject>Physiological aspects</subject><subject>Transplantation</subject><subject>Transplants &amp; implants</subject><subject>Viral antibodies</subject><issn>0002-9173</issn><issn>1943-7722</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNptjU1LAzEYhIMoWKsn_0DA87b53A9vS7FaqailvXhZssmbNmW7qdms4L93QUEPMoeB4ZkZhK4pmVBS8Gn5OHuZlq9vRIgTNKKF4EmWMXaKRoQQlhQ04-foouv2hFCWEzFCmxXoPgRoI14Y548q7pzGS_cBAZdN47dB2YjnyjV9gFu83gFe-Qawt7hso6u9-UyewDgVweAV7EFH59tLdGZV08HVj4_RZn63nj0ky-f7xaxcJluak5gwTQ1jItNFDZnQeUqlsGktDWFagMhpTbmobWqNFIUSBdGMcEmZ5AYG0PAxuvnePQb_3kMXq73vQztcVozzgso0l_yX2qoGKtdaH4PSB9fpqkxFTnKRy3SgJv9QgwwcnPYtWDfkfwpfmclsqg</recordid><startdate>20190901</startdate><enddate>20190901</enddate><creator>Schiano, Thomas D</creator><creator>Florman, Sander</creator><creator>Fiel, M. Isabel</creator><general>Oxford University Press</general><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20190901</creationdate><title>Recurrent Idiopathic Liver Allograft Failure: The Role of Antibody-Mediated Rejection</title><author>Schiano, Thomas D ; Florman, Sander ; Fiel, M. Isabel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g180t-2c1d2247c9be74c86154f6b5d02c4e481b134bf6fd549a490c20351253de4f6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Allografts</topic><topic>Antibodies</topic><topic>Biopsy</topic><topic>Causes of</topic><topic>Development and progression</topic><topic>Etiology</topic><topic>Explants</topic><topic>Graft rejection</topic><topic>Health aspects</topic><topic>Liver</topic><topic>Liver diseases</topic><topic>Liver transplantation</topic><topic>Liver transplants</topic><topic>Physiological aspects</topic><topic>Transplantation</topic><topic>Transplants &amp; implants</topic><topic>Viral antibodies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schiano, Thomas D</creatorcontrib><creatorcontrib>Florman, Sander</creatorcontrib><creatorcontrib>Fiel, M. Isabel</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>American journal of clinical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schiano, Thomas D</au><au>Florman, Sander</au><au>Fiel, M. Isabel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recurrent Idiopathic Liver Allograft Failure: The Role of Antibody-Mediated Rejection</atitle><jtitle>American journal of clinical pathology</jtitle><date>2019-09-01</date><risdate>2019</risdate><volume>152</volume><issue>3</issue><spage>369</spage><epage>376</epage><pages>369-376</pages><issn>0002-9173</issn><eissn>1943-7722</eissn><abstract>Objectives: Many transplant programs have had patients who develop idiopathic recurrent liver allograft failure, necessitating serial transplants, and are deemed to have refractory or recurrent rejection. The frequency and the etiology of this immunologic dysfunction have not been well characterized. Methods: Herein, we illustrate the case of a patient who required three retransplants over a period of 20 years for recurrent liver allograft failure. By extensively compiling the patient's many liver biopsy specimens and explants over time, we demonstrate that antibody-mediated rejection (AMR) was a major contributing factor from the outset. We conducted a review of the Scientific Registry for Transplant Recipients database to estimate the potential frequency of AMR. Results: As illustrated by this case, AMR has varied histologic findings in the setting of elevated donor-specific antibody titers. Conclusions: The cause of recurrent allograft failure in this patient was likely a combination of acute cellular rejection and AMR, manifestations of likely underlying immune dysregulation. Pathologists and transplant physicians should recognize the variable histologic presentations of AMR, which is imperative for its timely intervention. This case demonstrates how difficult the diagnosis of AMR can be to make, highlighting the need for strong clinical suspicion in patients having difficult-to-treat rejection and recurrent allograft failure. Key Words: Allograft failure; Rejection; Liver transplantation; Retransplantation</abstract><cop>Chicago</cop><pub>Oxford University Press</pub><doi>10.1093/AJCP/AQZ044</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9173
ispartof American journal of clinical pathology, 2019-09, Vol.152 (3), p.369-376
issn 0002-9173
1943-7722
language eng
recordid cdi_proquest_journals_2339156853
source Oxford Journals Online
subjects Allografts
Antibodies
Biopsy
Causes of
Development and progression
Etiology
Explants
Graft rejection
Health aspects
Liver
Liver diseases
Liver transplantation
Liver transplants
Physiological aspects
Transplantation
Transplants & implants
Viral antibodies
title Recurrent Idiopathic Liver Allograft Failure: The Role of Antibody-Mediated Rejection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A53%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recurrent%20Idiopathic%20Liver%20Allograft%20Failure:%20The%20Role%20of%20Antibody-Mediated%20Rejection&rft.jtitle=American%20journal%20of%20clinical%20pathology&rft.au=Schiano,%20Thomas%20D&rft.date=2019-09-01&rft.volume=152&rft.issue=3&rft.spage=369&rft.epage=376&rft.pages=369-376&rft.issn=0002-9173&rft.eissn=1943-7722&rft_id=info:doi/10.1093/AJCP/AQZ044&rft_dat=%3Cgale_proqu%3EA648084856%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g180t-2c1d2247c9be74c86154f6b5d02c4e481b134bf6fd549a490c20351253de4f6d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2339156853&rft_id=info:pmid/&rft_galeid=A648084856&rfr_iscdi=true